These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1318677)

  • 81. Surveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001.
    Vanhoof R; Carpentier M; Cartuyvels R; Damée S; Fagnart O; Garrino MG; Glupczynski Y; Gordts B; Govaerts D; Magerman K; Mans I; Surmont I; Van Bossuyt E; Van De Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
    Acta Clin Belg; 2003; 58(2):111-9. PubMed ID: 12836494
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Azithromycin and clarithromycin: overview and comparison with erythromycin.
    Whitman MS; Tunkel AR
    Infect Control Hosp Epidemiol; 1992 Jun; 13(6):357-68. PubMed ID: 1320067
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antibiotic-resistant mutants of Mycoplasma pneumoniae.
    Stopler T; Gerichter CB; Branski D
    Isr J Med Sci; 1980 Mar; 16(3):169-73. PubMed ID: 6771227
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1991 Mar; 35(3):587-9. PubMed ID: 1903913
    [TBL] [Abstract][Full Text] [Related]  

  • 85. In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
    Segreti J; Kessler HA; Kapell KS; Trenholme GM
    Antimicrob Agents Chemother; 1987 Jan; 31(1):100-1. PubMed ID: 2952061
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
    Sugita K; Katouno Y; Uchida H; Kobayashi Y
    Jpn J Antibiot; 2002 Dec; 55(6):771-7. PubMed ID: 12621731
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.
    Kuo CC; Jackson LA; Lee A; Grayston JT
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2669-70. PubMed ID: 8913488
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities.
    Poulsen RL; Knudsen JD; Petersen MB; Fuursted K; Espersen F; Frimodt-Møller N
    APMIS; 1996 Mar; 104(3):227-33. PubMed ID: 8611198
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Susceptibility of Chlamydia trachomatis to trovafloxacin.
    Jones RB; Van der Pol B; Johnson RB
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():63-5. PubMed ID: 9222072
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.
    Johannisson G; Sernryd A; Lycke E
    Sex Transm Dis; 1979; 6(2):50-7. PubMed ID: 494040
    [TBL] [Abstract][Full Text] [Related]  

  • 91. In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia.
    Niki Y; Kimura M; Miyashita N; Soejima R
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2296-9. PubMed ID: 7840560
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
    Ednie LM; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Growth cycle-dependent pharmacodynamics of antichlamydial drugs.
    Siewert K; Rupp J; Klinger M; Solbach W; Gieffers J
    Antimicrob Agents Chemother; 2005 May; 49(5):1852-6. PubMed ID: 15855506
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.
    Kuo CC; Wang SP; Grayston JT
    Antimicrob Agents Chemother; 1977 Jul; 12(1):80-3. PubMed ID: 883821
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Inhibition of Chlamydia trachomatis growth in mouse fibroblasts by liposome-encapsulated tetracycline.
    al-Awadhi H; Stokes GV; Reich M
    J Antimicrob Chemother; 1992 Sep; 30(3):303-11. PubMed ID: 1452495
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.
    Retsema J; Girard A; Schelkly W; Manousos M; Anderson M; Bright G; Borovoy R; Brennan L; Mason R
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1939-47. PubMed ID: 2449865
    [TBL] [Abstract][Full Text] [Related]  

  • 97. In vitro activity of ofloxacin against Chlamydia trachomatis.
    Schachter J; Moncada JV
    Am J Med; 1989 Dec; 87(6C):14S-16S. PubMed ID: 2690615
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.
    Kimura M; Kishimoto T; Niki Y; Soejima R
    Antimicrob Agents Chemother; 1993 Apr; 37(4):801-3. PubMed ID: 8494377
    [TBL] [Abstract][Full Text] [Related]  

  • 100. In vitro activity of azithromycin against bacterial enteric pathogens.
    Gordillo ME; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1993 May; 37(5):1203-5. PubMed ID: 8390813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.